| Jenna Gloria Gardner, CAA | |
|
10315 Dawsons Creek Blvd Ste Ab, Fort Wayne, IN 46825-1912 | |
| (260) 436-7875 | |
| Not Available |
| Full Name | Jenna Gloria Gardner |
|---|---|
| Gender | Female |
| Speciality | Anesthesiology Assistant |
| Experience | 2 Years |
| Location | 10315 Dawsons Creek Blvd Ste Ab, Fort Wayne, Indiana |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003560277 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367H00000X | Anesthesiologist Assistant | AA2000022 (District Of Columbia) | Secondary |
| 367H00000X | Anesthesiologist Assistant | 75000170A (Indiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Medstar Washington Hospital Center | Washington, DC | Hospital |
| Physicians' Medical Center Llc | New albany, IN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Medstar Medical Group Anesthesiology Llc | 1052678034 | 456 |
| Associated Anesthesiologists Of Fort Wayne, Pc | 2264412444 | 102 |
News Archive
Results from the PrefHer (Patient Preference for Subcutaneous (SC) versus Intravenous (IV) Herceptin) trial show that 92% of early HER2-positive breast cancer patients favoured quicker SC administration of Herceptin compared to the standard IV infusion.1 Presented at the St. Gallen Breast Cancer Conference in Switzerland.
College students may realize that texting in the shower or at a funeral is inappropriate, but many do it anyway, according to Penn State psychologists.
A new study provides compelling evidence that a simple tool can help predict which patients with cancer may be in their final year of life. The tool, known as the Surprise Question, was found to predict the risk of cancer death within one year better than factors such as cancer type or stage alone. This study will be presented at the upcoming 2015 Palliative Care in Oncology Symposium in Boston.
Clinical descriptors can assist clinicians in identifying patients with various stages of atherothrombosis (abnormal fatty deposits in an artery) who are at high-risk of future cardiovascular events, according to a study that will appear in the September 22 issue of JAMA. The study is being released early online to coincide with its presentation at the European Society of Cardiology meeting in Stockholm.
In FDLI's latest monograph, Selling Pharmaceuticals and Biologics to the Federal Government: Federal Supply Schedule and Federal Pricing Requirements, Joy Sturm, Allison Pugsley and Stephen A. Smyers of Hogan Lovells US LLP detail how pharmaceutical and biologics manufacturers can deal effectively with government contracting requirements and price calculation requirements.
› Verified 8 days ago
| Entity Name | Medstar Medical Group Anesthesiology Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528578333 PECOS PAC ID: 1052678034 Enrollment ID: O20171129001837 |
News Archive
Results from the PrefHer (Patient Preference for Subcutaneous (SC) versus Intravenous (IV) Herceptin) trial show that 92% of early HER2-positive breast cancer patients favoured quicker SC administration of Herceptin compared to the standard IV infusion.1 Presented at the St. Gallen Breast Cancer Conference in Switzerland.
College students may realize that texting in the shower or at a funeral is inappropriate, but many do it anyway, according to Penn State psychologists.
A new study provides compelling evidence that a simple tool can help predict which patients with cancer may be in their final year of life. The tool, known as the Surprise Question, was found to predict the risk of cancer death within one year better than factors such as cancer type or stage alone. This study will be presented at the upcoming 2015 Palliative Care in Oncology Symposium in Boston.
Clinical descriptors can assist clinicians in identifying patients with various stages of atherothrombosis (abnormal fatty deposits in an artery) who are at high-risk of future cardiovascular events, according to a study that will appear in the September 22 issue of JAMA. The study is being released early online to coincide with its presentation at the European Society of Cardiology meeting in Stockholm.
In FDLI's latest monograph, Selling Pharmaceuticals and Biologics to the Federal Government: Federal Supply Schedule and Federal Pricing Requirements, Joy Sturm, Allison Pugsley and Stephen A. Smyers of Hogan Lovells US LLP detail how pharmaceutical and biologics manufacturers can deal effectively with government contracting requirements and price calculation requirements.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jenna Gloria Gardner, CAA Po Box 843603, Dallas, TX 75284-3603 Ph: (972) 233-1999 | Jenna Gloria Gardner, CAA 10315 Dawsons Creek Blvd Ste Ab, Fort Wayne, IN 46825-1912 Ph: (260) 436-7875 |
News Archive
Results from the PrefHer (Patient Preference for Subcutaneous (SC) versus Intravenous (IV) Herceptin) trial show that 92% of early HER2-positive breast cancer patients favoured quicker SC administration of Herceptin compared to the standard IV infusion.1 Presented at the St. Gallen Breast Cancer Conference in Switzerland.
College students may realize that texting in the shower or at a funeral is inappropriate, but many do it anyway, according to Penn State psychologists.
A new study provides compelling evidence that a simple tool can help predict which patients with cancer may be in their final year of life. The tool, known as the Surprise Question, was found to predict the risk of cancer death within one year better than factors such as cancer type or stage alone. This study will be presented at the upcoming 2015 Palliative Care in Oncology Symposium in Boston.
Clinical descriptors can assist clinicians in identifying patients with various stages of atherothrombosis (abnormal fatty deposits in an artery) who are at high-risk of future cardiovascular events, according to a study that will appear in the September 22 issue of JAMA. The study is being released early online to coincide with its presentation at the European Society of Cardiology meeting in Stockholm.
In FDLI's latest monograph, Selling Pharmaceuticals and Biologics to the Federal Government: Federal Supply Schedule and Federal Pricing Requirements, Joy Sturm, Allison Pugsley and Stephen A. Smyers of Hogan Lovells US LLP detail how pharmaceutical and biologics manufacturers can deal effectively with government contracting requirements and price calculation requirements.
› Verified 8 days ago
Mark D Schamber, Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 11141 Parkview Plaza Dr Ste 200, Fort Wayne, IN 46845 Phone: 260-425-6030 Fax: 260-425-6028 | |
Emily Allan, Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 11141 Parkview Plaza Dr Ste 200, Fort Wayne, IN 46845 Phone: 260-425-6030 Fax: 260-425-6028 | |
Sebah Abdulaziz, Anesthesiologist Assistant Medicare: May Accept Medicare Assignments Practice Location: 11141 Parkview Plaza Dr Ste 200, Fort Wayne, IN 46845 Phone: 260-425-6030 Fax: 260-425-6028 | |
Brandon S Rentfrow, Anesthesiologist Assistant Medicare: Medicare Enrolled Practice Location: 11141 Parkview Plaza Dr Ste 200, Fort Wayne, IN 46845 Phone: 260-425-6030 Fax: 260-425-6028 | |
John Wesley Farver, AA-C Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 11141 Parkview Plaza Dr Ste 200, Fort Wayne, IN 46845 Phone: 260-425-6030 Fax: 260-425-6028 | |
Ryan Shane Tighe, Anesthesiologist Assistant Medicare: May Accept Medicare Assignments Practice Location: 11141 Parkview Plaza Dr Ste 200, Fort Wayne, IN 46845 Phone: 260-425-6030 Fax: 260-425-6028 |